All ongoing clinical trials need to be converted to Clinical Trials Information System ("CTIS") in accordance with Regulation (EU) 536/2014 ("CTR") by January 31, 2025. This date marks the end of a three-year transition period that began when the CTR came into force in the EU. Clinical trials that are not converted by the sponsor in time lose their legal basis and will have to be terminated by the National authority.
The Federal Office for Safety in Health Care (BASG) has been informed by the Italian authorities that in Italy, in addition to the provinces already announced, the ID WNV NAT test for donations of blood and blood components has been introduced in Rimini (Emilia-Romagna region).
The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that in Greece, in addition to the region already announced, confirmed human WNV infections have been recorded in Thessaloniki, Chalkidiki and Lefkada.
The Federal Office for Safety in Health Care (BASG) has been informed by the French authorities that a confirmed human dengue case has been recorded in the department of Hérault (Occitanie region).
The Federal Office relies on reports from consumers, health care professionals and companies for the continuous re-evaluation of the safety profile of medicinal products and medical devices.
The medicinal products database contains all products authorised in Austria, including up-to-date product information leaflets and the summary of products characteristics.
This is the subpage with information from the BASG directed to health care professionals (physicians, dentists, veterinarians, midwives and pharmacists).